Hong Kong Pharmaceuticals Stock News

SEHK:1171
SEHK:1171Oil and Gas

Yankuang Energy Group (SEHK:1171) Looks Cheap After Strong Buy Call And Higher Earnings Views

Yankuang Energy Group (SEHK:1171) is back in focus after recent analyst updates highlighted a higher consensus earnings outlook, a Strong Buy rating, and strong momentum and value scores that have drawn fresh investor attention. See our latest analysis for Yankuang Energy Group. At a share price of HK$12.23, Yankuang Energy Group has given investors a 25.44% year to date share price return and a 61.36% total shareholder return over the past year. However, momentum has cooled recently, with...
SEHK:237
SEHK:237Real Estate

Safety Godown Company (SEHK:237) Stock Losses Narrow In H1 2026 Challenging Bearish Narratives

Safety Godown Company (SEHK:237) has released its H1 2026 numbers, reporting revenue of HK$139.0 million and a net loss of HK$17.6 million, equal to a basic EPS loss of HK$0.04. The trailing 12 month figures show revenue of HK$235.0 million and a net loss of HK$283.3 million, or a basic EPS loss of HK$0.70. Over recent halves, the company has seen revenue move from HK$115.2 million in H1 2025 to HK$96.0 million in H2 2025 and then to HK$139.0 million in H1 2026. EPS shifted from roughly...
SEHK:992
SEHK:992Tech

Lenovo Group (SEHK:992) Expands Hybrid AI Tools, Is It Still A Bargain?

Lenovo Group (SEHK:992) recently expanded its Hybrid AI Advantage portfolio, introducing new AI inferencing and agentic AI tools aimed at helping enterprises deploy AI agents more efficiently and at lower operating cost across devices and data centers. See our latest analysis for Lenovo Group. The recent Hybrid AI announcements, new tablet launch and a completed US$2b zero coupon convertible bond sit against a backdrop of strong momentum, with a 30-day share price return of 45.52% and a...
SEHK:1672
SEHK:1672Biotechs

Is Ascletis Pharma (SEHK:1672) Undervalued On FDA Clearance For ASC35?

Ascletis Pharma (SEHK:1672) has attracted investor attention after receiving U.S. FDA Investigational New Drug clearance for ASC35, a once-monthly dual GLP-1/GIP agonist that is being advanced into a Phase I obesity trial. See our latest analysis for Ascletis Pharma. The FDA IND clearance arrives after a volatile year for Ascletis Pharma, with the share price down 35.2% over the past month and 37.9% over three months, while still delivering a 3-year total shareholder return of 418.5% and a...
SEHK:2536
SEHK:2536Hospitality

Palasino Holdings (SEHK:2536) Stock Faces Thin 2.3% Margin Reinforcing Bearish Narratives

Palasino Holdings (SEHK:2536) has reported its FY 2026 first half results with revenue of HK$305.2 million and basic EPS of HK$0.014, setting the tone for a period where profitability and scale are firmly in focus. Over the last three reported halves, the company has seen revenue move from HK$282.1 million in FY 2025 H1 to HK$286.1 million in FY 2025 H2 and now HK$305.2 million in FY 2026 H1. Basic EPS shifted from HK$0.019 in FY 2025 H1 to a slight loss in FY 2025 H2 before landing at...
SEHK:2633
SEHK:2633Pharmaceuticals

Jacobson Pharma (SEHK:2633) Stock Margins Near 19% Reinforce Bullish Earnings Narratives

Jacobson Pharma (SEHK:2633) has reported first half FY 2026 revenue of HK$766.6 million and basic EPS of HK$0.071, with trailing twelve month revenue at HK$1.6 billion and EPS at HK$0.151, giving investors a clear view of its recent earnings power. The company has seen half yearly revenue move from HK$810.0 million and EPS of HK$0.071 in the first half of FY 2025 to HK$766.9 million and EPS of HK$0.081 in the second half of FY 2025. This sets the stage for the latest numbers to be read...
SEHK:6063
SEHK:6063Construction

Lotus Horizon Holdings (SEHK:6063) Stock Faces Tension Between Profitable Half And TTM Loss

Lotus Horizon Holdings (SEHK:6063) has opened FY 2026 with first half revenue of HK$120.0 million and basic EPS of HK$0.000647, against a trailing 12 month picture where revenue was HK$226.0 million and the company reported a net loss of HK$3.3 million and EPS of HK$0.0017. Over the past three reported half year periods, revenue has moved from HK$130.7 million with EPS of HK$0.001009 in 1H FY 2025 to HK$129.2 million with EPS of HK$0.000587 in 2H FY 2025, and then to HK$120.0 million with EPS...
SEHK:9885
SEHK:9885Healthcare

June 2026's Top Penny Stock Opportunities In Global

Global markets have been influenced by key developments, such as the Federal Reserve's decision to hold interest rates steady and the Bank of Japan's rate hike to a 31-year high. Against this backdrop, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for investors seeking growth potential at lower price points. While the term "penny stocks" may seem outdated, these investments can still present valuable prospects when they exhibit strong...
SEHK:2235
SEHK:2235Medical Equipment

3 Asian Stocks That Might Be Trading Up To 28.9% Below Intrinsic Value Estimates

As global markets navigate a complex landscape of monetary policy shifts and geopolitical developments, Asian equities have shown resilience amid mixed economic signals. With Japan's stock markets surging to new heights and China grappling with uneven recovery, investors are keenly observing opportunities for undervalued stocks that might offer significant upside potential. Identifying stocks trading below their intrinsic value can be particularly appealing in such uncertain times, as these...
SEHK:700
SEHK:700Interactive Media and Services

Tencent Holdings (SEHK:700) Stock Could Be 58.4% Below Fair Value After Recent Weakness

Recent Performance Snapshot for Tencent Holdings stock Tencent Holdings (SEHK:700) has drawn investor attention after a period where the stock declined 4.2% over the past day, 7.3% over the past week and about 6% over the past month. Over the past 3 months, Tencent Holdings is down about 17.9%, with the year to date return showing a decline of 33.4%. On a 1 year basis, the total return is down 17.6%, while the 3 year total return stands at 25.1% and the 5 year total return reflects a decline...
SEHK:1982
SEHK:1982Luxury

Nameson Holdings (SEHK:1982) Stock Faces Softer Margins Challenging Earnings Resilience Narrative

Nameson Holdings (SEHK:1982) has just reported its FY 2026 first half results with revenue of HK$2.8b and basic EPS of HK$0.15, setting the tone for how the rest of the year could unfold. The company has seen revenue move from HK$2.8b with EPS of HK$0.13 in FY 2025 first half to HK$1.6b with EPS of HK$0.02 in FY 2025 second half before reaching HK$2.8b and EPS of HK$0.15 in the latest FY 2026 first half, giving investors a clearer read on how earnings power is tracking through the cycle. With...
SEHK:1211
SEHK:1211Auto

3 AI Infrastructure Stocks With High Insider Ownership And Growth

Growth has become harder to find as major economies send mixed signals, from weak European PMIs and contracting UK services to patchy strength across Asia and Latin America. In this kind of stop start backdrop, many investors are looking for companies where management is clearly aligned with shareholders and analysts see room for further expansion. The Fast Growing Stocks With High Insider Ownership screener focuses on exactly that combination. It highlights businesses where insiders have...
SEHK:2161
SEHK:2161Pharmaceuticals

JBM (Healthcare) (SEHK:2161) Stock Faces Margin Slippage Question As Net Margin Eases To 24.1%

JBM (Healthcare) (SEHK:2161) has posted its FY 2026 first half results with revenue of HK$429.6 million and basic EPS of HK$0.141, setting the stage for how investors assess the latest move in profitability. The company has reported revenue of HK$398.9 million in FY 2025 H1, HK$383.3 million in FY 2025 H2, and HK$429.6 million in FY 2026 H1, while basic EPS was HK$0.116 in FY 2025 H1, HK$0.108 in FY 2025 H2, and HK$0.141 in the latest half. These figures sit against a slightly softer net...
SEHK:9669
SEHK:9669Software

Beisen Holding (SEHK:9669) Stock Sees Losses Narrow Sharply In Latest Half Challenging Bears

Beisen Holding (SEHK:9669) has reported its FY 2026 first half with revenue of C¥516.0 million and a loss per share of C¥0.03, alongside trailing twelve month revenue of C¥1.10 billion and a TTM loss per share of C¥0.03. The company has seen revenue move from C¥436.6 million in 1H FY 2025 to C¥508.5 million in 2H FY 2025 and then to C¥516.0 million in 1H FY 2026. Losses per share shifted from C¥0.14 in 1H FY 2025 to C¥0.07 in 2H FY 2025 and C¥0.03 in 1H FY 2026, setting up an earnings season...
SEHK:1138
SEHK:1138Oil and Gas

COSCO SHIPPING Energy Transportation (SEHK:1138) Stock Could Be 4.6% Below Fair Value After SSE 180 Addition

Why the SSE 180 Index Addition Matters for COSCO SHIPPING Energy Transportation COSCO SHIPPING Energy Transportation (SEHK:1138) was recently added to the SSE 180 Index, a move that can draw more attention from institutional investors and index-tracking funds. This index inclusion often leads to higher visibility in the domestic market, which can influence trading volumes and liquidity. For existing and potential shareholders, the change raises questions about how the stock’s fundamentals...
SEHK:9636
SEHK:9636Capital Markets

JF SmartInvest Holdings (SEHK:9636) Stock Looks Fully Valued After Rebrand Draws Fresh Attention

Why JF SmartInvest Holdings’ Rebrand Is Drawing Fresh Attention JF SmartInvest Holdings (SEHK:9636) recently rebranded from JF Wealth Holdings, highlighting a clearer focus on online investment decision-making solutions at a time when the stock has retreated over the past month and the past 3 months. See our latest analysis for JF SmartInvest Holdings. For context, JF SmartInvest Holdings’ share price has fallen year to date. Its 1-day share price return of 13.08% stands out against a 30-day...
SEHK:6933
SEHK:6933Entertainment

Sino-Entertainment Technology Holdings And 2 Other Asian Penny Stocks To Consider

Amidst a backdrop of shifting monetary policies and mixed economic signals in Asia, investors are closely watching regional markets for opportunities. Penny stocks, often associated with smaller or emerging companies, continue to capture interest due to their potential for substantial growth when supported by strong financials. While the term "penny stock" may seem outdated, the investment potential remains significant as these companies can offer unique value propositions that larger firms...